Chasing Brilinta payoff, AZ details THALES data in ischemic ...

AstraZeneca has lifted the veil on the large-scale THALES trial of its antiplatelet drug Brilinta in stroke, the company’s last big hope for recouping its substantial investmen

Novo Nordisk diversifies with $2.1bn deal to buy Corvidia

Novo Nordisk has taken another step towards expanding beyond its heartlands of diabetes and obesity with a deal to buy US biotech Corvidia Therapeutics and its lead drug for ch

Novartis strikes landmark deal with NHS to speed up inclisir...

AI specialist Exscientia signs drug discovery tie-up with Ba...

Apple launches Research app, along with three health studies

Amarin gets FDA panel okay for new Vascepa indication